Back to comparisons

Comparison

Caffeine vs Atomoxetine (Strattera)

FieldCaffeineAtomoxetine (Strattera)
Categorystimulantstimulant
Dose range50–400mg40–100mg
Half-life5h5h
Onset30min60min
EvidenceEVIDENCEAEVIDENCEA
Safety●●●●●●●●
Legal (US)USOTCUSRx
PubMed refs250003800

The comparison in plain English

Auto-generated from data

Caffeine and Atomoxetine (Strattera) are both in the stimulant category respectively. Caffeine The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. Atomoxetine (Strattera) Prescription non-stimulant ADHD medication.

Bottom line

Caffeine (evidence A, safety 4/5) matches the evidence base of Atomoxetine (Strattera) (evidence A, safety 4/5). Caffeine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Caffeine if

Caffeine is the better fit when your goal aligns with its mechanism (Competitively blocks adenosine A1 and A2A receptors) and the dose range (50–400mg) suits your protocol. Half-life is 5h.

Choose Atomoxetine (Strattera) if

Atomoxetine (Strattera) is the better fit when your goal aligns with its mechanism (Selective norepinephrine reuptake inhibitor (NRI) — blocks the norepinephrine transporter, increasing extracellular norepinephrine) and the dose range (40–100mg) suits your protocol. Half-life is 5h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →